Acute exacerbations of chronic obstructive pulmonary disease

被引:9
作者
Chabot, Francois [1 ]
Gomez, Emmanuel [1 ]
Guillaumot, Anne [1 ]
Kheir, Ayman [1 ]
Chaouat, Ari [1 ]
机构
[1] CHU Nancy, Hop Brabois, Serv Malad Resp & Reanimat Resp, F-54500 Vandoeuvre Les Nancy, France
来源
PRESSE MEDICALE | 2009年 / 38卷 / 03期
关键词
LUNG-FUNCTION DECLINE; COPD EXACERBATIONS; TIOTROPIUM; SURVIVAL; TRIAL; VENTILATION; VACCINATION; PREVENTION; PROPIONATE; SALMETEROL;
D O I
10.1016/j.lpm.2008.12.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute exacerbation of chronic obstructive pulmonary disease (COPD) is defined by modification of the usual COPD symptoms, dyspnea, coughing and sputum, beyond doily variations, with a sudden onset, and requiring modification of the usual treatment. Exacerbations stud the course of COPD. Their frequency is variable, averaging 1-2 per year. Their frequency generally increases with COPD severity. Exacerbations impair patients' quality of life and aggravate disease prognosis by accelerating the decline in FEV1, the primary indicator of respiratory function. The most frequent causes of exacerbations are viral and bacterial respiratory infections and pollution. No cause is identified for nearly one third of off exacerbations. Most exacerbations con be treated at home, if a careful search for signs of clinical severity is negative. Treatment combines inhaled bronchodilator agents (beta-2 agonists, combined if necessary with anticholinergics) and oral corticosteroid therapy (prednisone: 0.5 mg/kg/d for I week) when the COPD is severe or signs of severity accompany the exacerbation. Antibiotic therapy is justified when the sputum appears purulent. Severe exacerbation may require oxygen therapy in cases of severe hypoxemia (PaO2 < 60 mm Hg) or mechanically assisted ventilation, essentially by noninvasive ventilation in cases of respiratory acidosis (pH < 7.35). Noninvasive ventilation improves dyspnea and respiratory acidosis, diminishes respiratory frequency, intubation, duration of hospitalization, nosocomial infections, and mortality. Pulmonary follow-up is necessary offer on exacerbation, especially to prevent the recurrence of exacerbations by measures that have been demonstrated to be effective, including help in smoking cessation, adaptation of COPD treatment, vaccination against influena and pneumonia (pneumococci), and respiratory rehabilitation. Early diagnosis and rapid treatment of exacerbations can limit their impact, improve quality of life, and reduce the risk of hospitalization.
引用
收藏
页码:485 / 495
页数:11
相关论文
共 45 条
  • [1] Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial
    Aaron, Shawn D.
    Vandemheen, Katherine L.
    Fergusson, Dean
    Maltais, Francois
    Bourbeau, Jean
    Goldstein, Roger
    Balter, Meyer
    O'Donnell, Denis
    McIvor, Andrew
    Sharma, Sat
    Bishop, Graham
    Anthony, John
    Cowie, Robert
    Field, Stephen
    Hirsch, Andrew
    Hernandez, Paul
    Rivington, Robert
    Road, Jeremy
    Hoffstein, Victor
    Hodder, Richard
    Marciniuk, Darcy
    McCormack, David
    Fox, George
    Cox, Gerard
    Prins, Henry B.
    Ford, Gordon
    Bleskie, Dominique
    Doucette, Steve
    Mayers, Irvin
    Chapman, Kenneth
    Zamel, Noe
    FitzGerald, Mark
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) : 545 - U15
  • [2] Clinical efficacy of anti-pneumococcal vaccination in patients with COPD
    Alfageme, I
    Vazquez, R
    Reyes, N
    Muñoz, J
    Fernández, A
    Hernandez, M
    Merino, M
    Perez, J
    Lima, J
    [J]. THORAX, 2006, 61 (03) : 189 - 195
  • [3] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ANTHONISEN, NR
    MANFREDA, J
    WARREN, CPW
    HERSHFIELD, ES
    HARDING, GKM
    NELSON, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 196 - 204
  • [4] Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease
    Barbera, JA
    Roca, J
    Ferrer, A
    Felez, MA
    Diaz, O
    Roger, N
    RodriguezRoisin, R
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (06) : 1285 - 1291
  • [5] Characteristics and long-term outcome of acute exacerbations in chronic obstructive pulmonary disease:: an analysis of cases in the Swedish Intensive Care Registry during 2002-2006
    Berkius, J.
    Nolin, T.
    Mardh, C.
    Karlstrom, G.
    Walther, S. M.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2008, 52 (06) : 759 - 765
  • [6] *BPCO, 2003, REV MAL RESPIR, V20
  • [7] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) : 775 - 789
  • [8] Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
    Celli, BR
    MacNee, W
    Agusti, A
    Anzueto, A
    Berg, B
    Buist, AS
    Calverley, PMA
    Chavannes, N
    Dillard, T
    Fahy, B
    Fein, A
    Heffner, J
    Lareau, S
    Meek, P
    Martinez, F
    McNicholas, W
    Muris, J
    Austegard, E
    Pauwels, R
    Rennard, S
    Rossi, A
    Siafakas, N
    Tiep, B
    Vestbo, J
    Wouters, E
    ZuWallack, R
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 932 - 946
  • [9] Prevention of COPD exacerbations:: how to conduct a clinical trial evaluating the benefits of inhaled steroids?
    Chabot, F
    Devillier, P
    Drugeon, H
    Dusser, D
    Fournier, M
    Gaillat, J
    Grouin, JM
    Housset, B
    Huchon, G
    Léophonte, P
    Muir, JF
    Raffy, O
    Tonnel, AB
    Tremolieres, F
    Zück, P
    Attali, V
    Boucot, I
    Chemali-Hudry, J
    Daniloski, M
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (04) : 685 - 688
  • [10] Chabot F, 2001, REV MAL RESPIR, V18, P267